Bullish option flow detected in Avadel Pharmaceuticals with 1,951 calls trading, 2x expected, and implied vol increasing over 4 points to 93.02%. Oct-24 10 puts and Oct-24 17.5 calls are the most active options, with total volume in those strikes near 1,500 contracts. The Put/Call Ratio is 0.48. Earnings are expected on November 6th.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVDL:
- Avadel Pharmaceuticals call volume above normal and directionally bullish
- Avadel Pharmaceuticals Advances Pediatric Narcolepsy Treatment Review
- Avadel publishes RESTORE data on LUMRYZ for narcolepsy patients
- Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)
- H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’